Heme oxygenase-1 and carbon monoxide in vascular pathobiology

被引:267
作者
Dulak, Jozef [3 ]
Deshane, Jessy [2 ]
Jozkowicz, Alicja [3 ]
Agarwal, Anupam [1 ,2 ]
机构
[1] Univ Alabama, Div Nephrol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Ctr Nephrol Res & Training, Ctr Free Rad Biol,Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & biotechnol, Krakow, Poland
基金
英国惠康基金;
关键词
angiogenesis; antioxidants; endothelium; vasculature; growth substances; hypoxia; nitric oxide;
D O I
10.1161/CIRCULATIONAHA.107.698316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiogenesis involves the formation of new blood vessels and is critical for fundamental events such as development and repair after injury. Perturbances in angiogenesis contribute to the pathogenesis of diverse clinical conditions including cancer, complications of diabetes mellitus, ischemia/reperfusion injury of the heart and other organs, and preeclampsia, as well as a number of inflammatory disorders. Recent work has identified heme oxygenase-1 and its gaseous product, carbon monoxide, to possess potent proangiogenic properties in addition to well-recognized antiinflammatory, antioxidant, and antiapoptotic effects. Angiogenic factors, such as vascular endothelial growth factor and stromal cell-derived factor-1, mediate their proangiogenic effects through induction of heme oxygenase-1, making it an attractive target for therapeutic intervention. This review will provide an overview of the role of heme oxygenase-1 and carbon monoxide in angiogenesis.
引用
收藏
页码:231 / 241
页数:11
相关论文
共 127 条
[91]   INDUCTION OF HEME OXYGENASE IS A RAPID, PROTECTIVE RESPONSE IN RHABDOMYOLYSIS IN THE RAT [J].
NATH, KA ;
BALLA, G ;
VERCELLOTTI, GM ;
BALLA, J ;
JACOB, HS ;
LEVITT, MD ;
ROSENBERG, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :267-270
[92]  
Nishie A, 1999, CLIN CANCER RES, V5, P1107
[93]   Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity [J].
Nowis, D. ;
Legat, M. ;
Grzela, T. ;
Niderla, J. ;
Wilczek, E. ;
Wilczynski, G. M. ;
Glodkowska, E. ;
Mrowka, P. ;
Issat, T. ;
Dulak, J. ;
Jozkowicz, A. ;
Was, H. ;
Adamek, M. ;
Wrzosek, A. ;
Nazarewski, S. ;
Makowski, M. ;
Stoklosa, T. ;
Jakobisiak, M. ;
Golab, J. .
ONCOGENE, 2006, 25 (24) :3365-3374
[94]   A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells [J].
Pae, HO ;
Oh, GS ;
Choi, BM ;
Kim, YM ;
Chung, HT .
ENDOCRINOLOGY, 2005, 146 (05) :2229-2238
[95]   The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis [J].
Petit, Isabelle ;
Jin, David ;
Rafii, Shahin .
TRENDS IN IMMUNOLOGY, 2007, 28 (07) :299-307
[96]   Heme oxygenase 1 is required for mammalian iron reutilization [J].
Poss, KD ;
Tonegawa, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10919-10924
[97]   Hypoxia signalling in cancer and approaches to enforce tumour regression [J].
Pouyssegur, Jacques ;
Dayan, Frederic ;
Mazure, Nathalie M. .
NATURE, 2006, 441 (7092) :437-443
[98]   Cardiac cell therapy - Mixed results from mixed cells [J].
Rosenzweig, Anthony .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1274-1277
[99]   Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner [J].
Salinas, M ;
Diaz, R ;
Abraham, NG ;
de Galarreta, CMR ;
Cuadrado, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13898-13904
[100]   Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells [J].
Sasaki, T ;
Yoshida, K ;
Kondo, H ;
Ohmori, H ;
Kuniyasu, H .
VIRCHOWS ARCHIV, 2005, 446 (05) :525-531